MarketWatch
Catalent Stock Rockets 21% Premarket On Report Of Takeover Interest From Danaher
Ciara Linnane
MarketWatch
Life Sciences Company Danaher Corp. (DHR) is interested in taking over contract manufacturer Catalent Inc. (CTLT) and is willing to pay a significant premium for the company, Bloomberg reported Monday, citing people familiar with the matter.
It's unclear whether Catalent is receptive, the people said, adding that a deal is not imminent. Catalent declined to comment, while Danaher did not respond to Bloomberg's request for comment. The report sent Catalent stock up 21% in premarket trade.
Catalent is based in Somerset, New Jersey, and provides delivery technologies for drugs, biologics and consumer health products, including producing vaccines for Moderna (MRNA) and Johnson & Johnson (JNJ). It has a market cap of just over $10 billion, according to FactSet.
